Well said Ted the oils are not where it is at although great for income . The company has multiple biotech plays with universal application that are company makers on successful completion any of the trials . Add the psychedelics and doc Litnaitzky to to mix and the company is excellently poised for a massive re rate . We are well on the way with IHL 675A . The current SP just may have something to do with as you say the pre-clinical success of IHL-675A and the pre IND meeting with the FDA .
The company is finally being recognised and we are IMO only at the beginning of a the journey . The potential is massive here .
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-2817
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online